Precipio, Inc.
NASDAQ:PRPO
Overview | Financials
Company Name | Precipio, Inc. |
Symbol | PRPO |
Currency | USD |
Price | 6.06 |
Market Cap | 8,982,920 |
Dividend Yield | 0% |
52-week-range | 4.31 - 7.3 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Ilan Danieli |
Website | https://www.precipiodx.com |
An error occurred while fetching data.
About Precipio, Inc.
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD